Patient 11 (according to the numbering shown in Table 1), had a BRCA1 E272* (c.814 G>T) mutation, in addition to another TP53 pathogenic mutation—TP53 R248Q (c.743 G>A)—that had been detected at diagnosis in the tumour tissue (Table 1). This evidence concerns the gene BRCA1 and neoplasm.